Showing results (641-650 of 782) with videos related to

Sort By:
Pageof 79
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Perifosine plus bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma previously treated with bortezomib: results of a multicenter phase I/II trialPaul G Richardson, Jeff Wolf, Andrzej Jakubowiak, et al.
Blood|January 5, 2023
High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myelomaMehmet Kemal Samur, Marco Roncador, Anil Aktas Samur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivoMasood A Shammas, Aamer Qazi, Ramesh B Batchu, et al.
Blood|June 4, 2026
PKMYT1 is a Targetable Vulnerability in del(17p) High-Risk Multiple MyelomaAnaïs Schavgoulidze, Jian Cui, Jessica Encinas, et al.
Blood|May 28, 2010
PI3K/p110{delta} is a novel therapeutic target in multiple myelomaHiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, et al.
Blood|September 1, 2007
The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemiaXavier Leleu, Xiaoying Jia, Judith Runnels, et al.
British Journal of Haematology|April 26, 2014
Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomideAndrew J Yee, Parameswaran Hari, Raffaella Marcheselli, et al.
Pageof 79